Multi-modal investigation of the schizophrenia-associated 3q29 genomic interval reveals global genetic diversity with unique haplotypes and segments that increase the risk for non-allelic homologous recombination NAHR

Chromosomal rearrangements that alter the copy number of dosage-sensitive genes can result in genomic disorders, such as the 3q29 deletion syndrome. At the 3q29 region, non-allelic homologous recombination (NAHR) between paralogous copies of segmental duplications (SDs) leads to a recurrent ~1.6 Mbp deletion or duplication, causing neurodevelopmental and psychiatric phenotypes. However, risk factors contributing to NAHR at this locus are not well understood. In this study, we used an optical mapping approach to identify structural variations within the 3q29 interval. We identified 18 novel haplotypes among 161 unaffected individuals and used this information to characterize this region in 18 probands with either the 3q29 deletion or 3q29 duplication syndrome. A significant amount of variation in haplotype prevalence was observed between populations. Within probands, we narrowed down the breakpoints to a ~5 kbp segment within the SD blocks in 89% of the 3q29 deletion and duplication cases studied. Furthermore, all 3q29 deletion and duplication cases could be categorized into one of five distinct classes based on their breakpoints. Contrary to previous findings for other recurrent deletion and duplication loci, there was no evidence for inversions in either parent of the probands mediating the deletion or duplication seen in this syndrome.

[1]  D. Cutler,et al.  Sex-specific recombination patterns predict parent of origin for recurrent genomic disorders , 2021, BMC Medical Genomics.

[2]  William T. Harvey,et al.  Haplotype-resolved diverse human genomes and integrated analysis of structural variation , 2021, Science.

[3]  Steven E. Sloan,et al.  Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care , 2021, Genetics in Medicine.

[4]  D. Ledbetter,et al.  Diagnostic genetic testing for neurodevelopmental psychiatric disorders: closing the gap between recommendation and clinical implementation. , 2021, Current opinion in genetics & development.

[5]  U. Surti,et al.  Genomic regions associated with microdeletion/microduplication syndromes exhibit extreme diversity of structural variation. , 2021, Genetics.

[6]  David I. K. Martin,et al.  Towards a reference genome that captures global genetic diversity , 2020, Nature Communications.

[7]  E. Walker,et al.  Comprehensive phenotyping of 3q29 deletion syndrome: recommendations for clinical care , 2020, medRxiv.

[8]  Hui Zhao,et al.  LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465. , 2020, Journal of biochemistry.

[9]  M. Zwick,et al.  New phenotypes associated with 3q29 duplication syndrome: Results from the 3q29 registry , 2020, American journal of medical genetics. Part A.

[10]  Pui-Yan Kwok,et al.  Genome maps across 26 human populations reveal population-specific patterns of structural variation , 2019, Nature Communications.

[11]  F. Yin,et al.  A Case With 4 de Novo Copy Number Variations With Clinical Features That Overlap 1q43q44 Microdeletion and 3q29 Microduplication Syndromes , 2018, Child neurology open.

[12]  T. Shaikh,et al.  The 22q11 low copy repeats are characterized by unprecedented size and structural variability , 2018, bioRxiv.

[13]  G. Gimelli,et al.  3q29 microduplication syndrome: Description of two new cases and delineation of the minimal critical region. , 2018, European journal of medical genetics.

[14]  Y. Mo,et al.  Role of Pseudogenes in Tumorigenesis , 2018, Cancers.

[15]  L. Pastore,et al.  3q29 microduplication in a small family with complex metabolic phenotype from Southern Italy , 2018, Clinical chemistry and laboratory medicine.

[16]  E. Walker,et al.  Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome , 2018, BMC Psychiatry.

[17]  J. Lupski,et al.  Genomic disorders 20 years on—mechanisms for clinical manifestations , 2018, Clinical genetics.

[18]  Nana Jin,et al.  OMTools: a software package for visualizing and processing optical mapping data , 2017, Bioinform..

[19]  J. Lupski,et al.  Mechanisms underlying structural variant formation in genomic disorders , 2016, Nature Reviews Genetics.

[20]  T. Thanaraj,et al.  Sequence and analysis of a whole genome from Kuwaiti population subgroup of Persian ancestry , 2015, BMC Genomics.

[21]  Xun Xu,et al.  Rapid detection of structural variation in a human genome using nanochannel-based genome mapping technology , 2014, GigaScience.

[22]  J. Albert,et al.  Cerebral palsy, epilepsy, and severe intellectual disability in a patient with 3q29 microduplication syndrome , 2014, American journal of medical genetics. Part A.

[23]  T. Thanaraj,et al.  Genome at Juncture of Early Human Migration: A Systematic Analysis of Two Whole Genomes and Thirteen Exomes from Kuwaiti Population Subgroup of Inferred Saudi Arabian Tribe Ancestry , 2014, PloS one.

[24]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[25]  U. Broeckel,et al.  Whole‐genome copy number variation analysis in anophthalmia and microphthalmia , 2013, Clinical genetics.

[26]  Edouard Hirsch,et al.  Epileptic encephalopathies of the Landau‐Kleffner and continuous spike and waves during slow‐wave sleep types: Genomic dissection makes the link with autism , 2012, Epilepsia.

[27]  P. Kwok,et al.  Genome mapping on nanochannel arrays for structural variation analysis and sequence assembly , 2012, Nature Biotechnology.

[28]  S. Salzberg,et al.  Repetitive DNA and next-generation sequencing: computational challenges and solutions , 2012, Nature Reviews Genetics.

[29]  P. Rahman,et al.  Genome-Wide Signatures of ‘Rearrangement Hotspots’ within Segmental Duplications in Humans , 2011, PloS one.

[30]  I. M. Trives,et al.  Síndrome de microduplicación 3q29 , 2011 .

[31]  S. Salzberg,et al.  Repetitive DNA and next-generation sequencing: computational challenges and solutions , 2011, Nature Reviews Genetics.

[32]  D. Cutler,et al.  Microdeletions of 3q29 confer high risk for schizophrenia. , 2010, American journal of human genetics.

[33]  C. Fowler,et al.  Williams-Beuren syndrome. , 2010, The New England journal of medicine.

[34]  Lars Feuk,et al.  Inversion variants in the human genome: role in disease and genome architecture , 2010, Genome Medicine.

[35]  P. Stankiewicz,et al.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size , 2009, Journal of Medical Genetics.

[36]  D. Ledbetter,et al.  Segmental duplications mediate novel, clinically relevant chromosome rearrangements. , 2009, Human molecular genetics.

[37]  Raymond Tellier,et al.  The Complete Sequence of a Human Parainfluenzavirus 4 Genome , 2009, Viruses.

[38]  Zhaoshi Jiang,et al.  Characterization of six human disease-associated inversion polymorphisms , 2009, Human molecular genetics.

[39]  S. Scherer,et al.  Molecular and clinical characterization of de novo and familial cases with microduplication 3q29: guidelines for copy number variation case reporting , 2009, Cytogenetic and Genome Research.

[40]  R. Tervo,et al.  Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication , 2008, Molecular Cytogenetics.

[41]  K. Doheny,et al.  3q29 interstitial microduplication: A new syndrome in a three‐generation family , 2008, American journal of medical genetics. Part A.

[42]  U. Surti,et al.  Discovery of a previously unrecognized microdeletion syndrome of 16p11.2–p12.2 , 2007, Nature Genetics.

[43]  J. Lupski,et al.  Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders , 2006, Neuron.

[44]  B. D. de Vries,et al.  3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. , 2005, American journal of human genetics.

[45]  M. Bayés,et al.  Mutational mechanisms of Williams-Beuren syndrome deletions. , 2003, American journal of human genetics.

[46]  K. Devriendt,et al.  No evidence for a parental inversion polymorphism predisposing to rearrangements at 22q11.2 in the DiGeorge/Velocardiofacial syndrome , 2003, European Journal of Human Genetics.

[47]  Stephen W. Scherer,et al.  A 1.5 million–base pair inversion polymorphism in families with Williams-Beuren syndrome , 2001, Nature Genetics.

[48]  C. Romano,et al.  Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations , 2001, Journal of medical genetics.

[49]  S. Scherer,et al.  Identification of genes from a 500-kb region at 7q11.23 that is commonly deleted in Williams syndrome patients. , 1996, Genomics.

[50]  Peter J. Scambler,et al.  22q11.2 deletion syndrome. , 2015, Nature reviews. Disease primers.